(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

HLIC HLSV572482 - 100" Flow Controller with 2 Needless Injection Sites, 40 Per/Cs

HLIC # HLSV572482 - 100
Part Number HLIC HLSV572482
SKU Number CIA7001669
Sell Unit CASE
Ships Within 24 Hours
List Price $168.88
Enter a valid quantity

This product has a minimum quantity of 20

Product Description

HLIC HLSV572482 - 100" Flow Controller with 2 Needless Injection Sites, 40 Per/Cs

IV Admin Set w/ 2 Needleless Injection Site & Flow Control

Slide clamp

Slide clamp used to regulate the flow of IV solution. The slide clamp has a graduated opening through which the IV tubing passes. Pushing the tube into the narrow end of the opening constricts it and reduces the flowrate of the IV solution. Sliding the wide end of the opening over the tube increases the flow rate.

What is Priming volume?

The amount of fluid required to fill the entire length of the IV administration set eliminating the air in line. At the beginning of an infusion, all IV sets are primed to avoid delivering air through the line. After the IV bag is spiked with the IV administration set, the IV solution/fluid flows through the tubing to remove the air. The priming volume of IV administration sets vary by manufacturer and affected by the length of the tubing and any add-on devices. The priming volume information can be found on the packaging label of the IV administration set.

DEHP Free

Infusion Therapy Standards of Practice advise to usee administration sets free of di-ethylhexyl-phthalate (DEHP) to administer lipid-based infusates, such as IVFE or TNA. DEHP is lipophilic and is extracted into the lipid solution with commonly used polyvinyl chloride administration sets and containers. DEHP is considered a toxin, and studies have demonstrated increased DEHP levels in lipid solutions, which is especially a risk with neonatal, pediatric, and long-term home care patients (42).